Shiral S Gangadin

11PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsDecision makingPersonality and individual differencesBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 14, 2026
Beyond the Need for Speed: D2 Receptor Affinity Predicts Relapse after Antipsychotic Tapering in First Episode Psychosis.

|Mar 21, 2026
The Impact of Sex and Age on Antipsychotic Serum Concentrations.

Franciska de Beer, Bodyl A Brand, Ben Wijnen

|Mar 09, 2026
External validation and recalibration of the psychosis metabolic risk calculator (PsyMetRiC) in young adults with chronic psychotic disorders in the Netherlands.

D M C Quadackers, B I Perry, S S Gangadin

|Jan 02, 2026
Negative association between cognitive functioning and antipsychotic D2 receptor occupancy, affinity, and dose after first episode psychosis.

Priscilla P Oomen, Shiral S Gangadin, Lieuwe de Haan

|Oct 28, 2025
Trajectories of Clozapine Concentrations in Women Across Menopausal Age.

Franciska de Beer, Iris M H Hamers, Michalina Prycka

|Sep 08, 2025
Dopamine D2/3R availability after discontinuation of antipsychotic treatment: a [11C]raclopride PET study in remitted first-episode psychosis patients.

Franciska de Beer, Erik de Vries, Ben Wijnen

Pageof 2

Frequent Collaborators

3 joint publications

Franciska de Beer

3 joint publications

Marieke J H Begemann

3 joint publications

Stynke Castelein

2 joint publications

Iris M H Hamers